KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cardlytics (CDLX) EPS (Basic) (2017 - 2025)

Cardlytics (CDLX) has disclosed EPS (Basic) for 9 consecutive years, with -$0.15 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EPS (Basic) rose 40.0% year-over-year to -$0.15, compared with a TTM value of -$1.95 through Dec 2025, up 50.51%, and an annual FY2025 reading of -$1.95, up 50.13% over the prior year.
  • EPS (Basic) was -$0.15 for Q4 2025 at Cardlytics, up from -$1.36 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $0.98 in Q1 2022 and bottomed at -$11.32 in Q4 2022.
  • Average EPS (Basic) over 5 years is -$1.37, with a median of -$0.62 recorded in 2024.
  • Peak annual rise in EPS (Basic) hit 215.29% in 2022, while the deepest fall reached 3437.5% in 2022.
  • Year by year, EPS (Basic) stood at -$0.32 in 2021, then plummeted by 3437.5% to -$11.32 in 2022, then surged by 75.8% to -$2.74 in 2023, then skyrocketed by 90.88% to -$0.25 in 2024, then soared by 40.0% to -$0.15 in 2025.
  • Business Quant data shows EPS (Basic) for CDLX at -$0.15 in Q4 2025, -$1.36 in Q3 2025, and -$0.18 in Q2 2025.